57.4 Ethical Considerations in Fertility Preservation for Transgender Youth

Abstract

Transgender adolescents and young adults (AYA) increasingly seek treatment with gender-affirming hormones (GAH). Although effective in reducing gender dysphoria (GD), GAH have long-term implications, including possible fertility impairment. Thus, clinical guidelines by the World Professional Association for Transgender Health, the Endocrine Society, and the American Society of Reproductive Medicine recommend counseling about fertility preservation (FP) options prior to starting GAH. Despite these recommendations, FP utilization is low among transgender AYA, with fewer than 5 percent completing FP.